Medtronic plc Executive Compensation
Named executive officer pay as disclosed in the company’s mdt-20250825.htm proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.
$21,240,058
Geoffrey S. Martha, Chief Executive Officer — total compensation
$1,350,000
base salary
Healthcare
industry
| Executive | Title | Base salary | Total compensation |
|---|---|---|---|
| Geoffrey S. Martha | Chairman and Chief Executive Officer Chairman and Chief Executive Officer | $1,350,000 | $21,240,058 |
| Sean M. Salmon | Former EVP & President, Cardiovascular Portfolio Former EVP & President, Cardiovascular Portfolio | $884,654 | $8,396,597 |
| Brett A. Wall | EVP & President, Neuroscience Portfolio | $774,519 | $8,121,213 |
| Gregory L. Smith | EVP Enterprise Operations | $894,560 | $8,083,981 |
| Thierry Piéton | Executive Vice President and Chief Financial Officer | $138,517 | $5,212,448 |
| Gary L. Corona | Former SVP Corporate Finance (former Interim CFO) | $466,346 | $3,795,248 |
| Karen L. Parkhill | Former Executive Vice President and Chief Financial Officer Former Executive Vice President and Chief Financial Officer | $262,856 | $270,679 |
Source: Medtronic plc Definitive Proxy Statement (DEF 14A), filed mdt-20250825.htm with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.
Other Healthcare companies
UNITEDHEALTH GROUP INC
Healthcare
$60,938,062
Stephen Hemsley, CEO
ELI LILLY & Co
Healthcare
$36,698,337
David A. Ricks, CEO
JOHNSON & JOHNSON
Healthcare
$32,758,111
J. Duato, CEO
AbbVie Inc.
Healthcare
$32,530,984
Robert A. Michael, CEO
GILEAD SCIENCES, INC.
Healthcare
$28,437,198
Daniel P, CEO
PFIZER INC
Healthcare
$27,585,301
A. Bourla, CEO
